Clinical Trial Update: SCOPE: Strategies to Combine PrEP With Prevention Efforts [NA]

View source ↗

Summary

The SCOPE trial assessing strategies to combine pre-exposure prophylaxis with HIV prevention efforts has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: FHI 360 | Conditions: HIV | NA | Status: WITHDRAWN